The Impact of Telemonitoring on Improving Glycemic and Metabolic Control in Previously Lost-to-Follow-Up Patients with Type 2 Diabetes Mellitus: A Single-Center Interventional Study in the United Arab Emirates

Table 2

Results of home-based devices of T2DM indicators at baseline and after three months.

Clinical characteristics (mean ± SD)	N	Baseline	N	3 months	N with both measures	Difference (95% CI) (3 months–baseline)	value
Blood glucose (mg/dL)
FBG	26	192.2 (61.4)	31	147.9 (40.3)	20	−40.1 (−70.8–−9.3)	0.013
RBG	32	199.5 (66.4)	25	171.3 (83.3)	21	−40.8 (−84.7–3.2)	0.067
Blood pressure (mmHg)
SBP	37	135.4 (15.3)	38	133.5 (15.1)	37	−2.2 (−7.2–2.8)	0.386
DBP	37	85.7 (11.7)	38	82.5 (9.4)	37	−3.5 (−6.6–−0.4)	0.028
Pulse rate (beats/min)	37	82.7 (12.5)	38	82.2 (15.4)	37	−0.7 (−4.5–3.1)	0.710
Oxygen saturation (%)	38	97.4 (1.4)	38	95.7 (12.7)	38	−1.8 (−5.9–2.4)	0.393

FBG: fasting blood glucose; RBG: random blood glucose; SBP: systolic blood pressure; DBP: diastolic blood pressure; CI: confidence interval.